Pricing Log in Create free account

InflaRx N.V. (IFRX) vs Pyxis Oncology, Inc. (PYXS)

InflaRx N.V. and Pyxis Oncology, Inc. are both Biotechnology companies. InflaRx N.V. and Pyxis Oncology, Inc. are of similar size ($198.6M and $192.3M). Across the 10 metrics below, InflaRx N.V. leads on 7 and Pyxis Oncology, Inc. on 3.

Valuation

Metric IFRX PYXS Biotechnology median
P/E n/m n/m 10.60
P/S 6,308.89 n/m 9.40
P/B 1.16 9.29 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,845.43 n/m 9.02
Earnings yield (29.70%) (84.94%) (32.88%)
Free cash flow yield (10.67%) (63.94%) (23.13%)

Profitability

Metric IFRX PYXS Biotechnology median
Gross margin (26,762.42%) 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (30.98%) (179.10%) (51.96%)
Return on assets (25.90%) (99.62%) (46.06%)
Return on invested capital (87.31%) 0.00% 0.00%

Growth

Metric IFRX PYXS Biotechnology median
Revenue growth (TTM) (83.39%) — 6.76%
EPS growth (last fiscal year) 9.41% 3.03% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IFRX PYXS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.26 1.34 4.97
Net debt to EBITDA 0.97 0.82 1.01

Dividend

Metric IFRX PYXS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IFRX PYXS Biotechnology median
Market cap 192.32m 198.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack